Tectonic Therapeutic Statistics
NASDAQ: TECXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
20.73-0.31 (-1.47%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tectonic Therapeutic by the numbers
Tectonic Therapeutic has a market capitalization of $405.3 million based on 19.55M shares outstanding. With trailing EPS of $-4.63, Tectonic Therapeutic is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.4% below its 50-day average and 26.2% below its 200-day average.
Average daily trading volume is 212.16K shares, or about $4.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TECX valuation vs. peer median
| Metric | TECX | Peer median | Difference |
|---|---|---|---|
| Market cap | $405.26M | $423.78M | -4% |
| Avg. volume | 212.16K | 1.33M | -84% |
Peer median across 8 companies: TVGN, CADL, PROK, IRLA, FENC, ALEC, RGNX, SANA.
Valuation
- Market cap
- $405.26M
- EPS (TTM)
- $-4.63
- Shares outstanding
- 19.55M
Price and trading
- Previous close
- 21.04
- Open
- 20.70
- Day range
- 20.41 – 21.57
- 52-week range
- 16.77 – 39.53
- 52-week change
- +8.08%
- Beta
- —
- Volume
- 268.83K
- Average volume
- 212.16K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 405.26M
- Forward Pe
- -4.36
- Eps
- -4.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 39.53
- Week52 Low
- 16.77
- Avg Volume
- 212.16K
- Shares Outstanding
- 19.55M
- Ma50
- 22.40
- Ma200
- 28.10
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -47.56%
- Pct From52w Low
- 23.61%